Look we are definitely not big pharma material, we

Look we are definitely not big pharma material, we have inexperienced "world class" management. Maybe we get lucky but the path is bumpy and sometimes it appears day to day. MRK signed three deals and is allover the news. Our MRK/AE37 project moves very very slow, Covid blamed, which imo total bs. Any new investors will be hesitant to get involved- terrible website, PR's most of the time pies in the sky and an office nothing but a rented place in an office complex(Google satellite). I think we need to add some experienced credible pharma top management to unlock the value if we have any. I still wouldn't mind if they sell the "value" and call it a day. Regardless Joe deserves to walk away with millions but so far since Nov 2018 the results have been disappointing!! A company with huge value and a credible management team will raise funds overnight and would have been listed in 2019!! Maybe a real PR firm can create excitement and interest to support the pps. Maybe we have a knowledgeable Board and scientists but we need business bankers to join us to open doors, move forward and actually get something done to generate real revenues !! A solid PR with S1, Altucell and NASDAQ update would be appreciated. China deal still pending or history? We need follow ups on past PR's , good or bad, but keep the shareholders in the loop. Lack of funding and miscalculated NASDAQ listing to support acquisition deals is causing many issues and headaches for the company!!
If a Covid vaccine is for real it could clean up the company very quickly but if we fail more valuable time lost ................lets hope BARDA won't take 90 days.

Links with good info.

https://www.phe.gov/about/amcg/BARDA-BAA/Page...-faqs.aspx

https://clinicaltrials.gov/ct2/show/NCT040248...amp;rank=1

https://www.medicalcountermeasures.gov/app/ba...VID19.aspx

https://srf.law/transactions/

https://epivax.com/press

https://www.who.int/who-documents-detail/draf...e-vaccines

https://www.marketwatch.com/tools/ipo-calendar